Free Trial

Cambridge Cognition (COG) Competitors

Cambridge Cognition logo
GBX 39.24 -0.76 (-1.90%)
As of 09/25/2025 11:21 AM Eastern

COG vs. KOO, RENX, INHC, FDBK, IQAI, DVRG, TRLS, SENS, EMIS, and CRW

Should you be buying Cambridge Cognition stock or one of its competitors? The main competitors of Cambridge Cognition include Kooth (KOO), Renalytix (RENX), Induction Healthcare Group (INHC), Feedback (FDBK), IQ-AI (IQAI), DeepVerge (DVRG), Trellus Health (TRLS), Sensyne Health (SENS), EMIS Group (EMIS), and Craneware (CRW). These companies are all part of the "health information services" industry.

Cambridge Cognition vs. Its Competitors

Cambridge Cognition (LON:COG) and Kooth (LON:KOO) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, media sentiment, institutional ownership and dividends.

Cambridge Cognition has a beta of 0.72, suggesting that its share price is 28% less volatile than the S&P 500. Comparatively, Kooth has a beta of 0.71, suggesting that its share price is 29% less volatile than the S&P 500.

Kooth has higher revenue and earnings than Cambridge Cognition. Cambridge Cognition is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cambridge Cognition£9.05M1.99-£1.58M-£0.04-1,032.63
Kooth£66.74M0.77£4.00M£0.21678.57

15.8% of Cambridge Cognition shares are owned by institutional investors. Comparatively, 28.3% of Kooth shares are owned by institutional investors. 3.8% of Cambridge Cognition shares are owned by insiders. Comparatively, 30.8% of Kooth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Kooth has a consensus price target of GBX 365, indicating a potential upside of 156.14%. Given Kooth's stronger consensus rating and higher probable upside, analysts plainly believe Kooth is more favorable than Cambridge Cognition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cambridge Cognition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Kooth
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Kooth has a net margin of 7.89% compared to Cambridge Cognition's net margin of -10.07%. Kooth's return on equity of 18.59% beat Cambridge Cognition's return on equity.

Company Net Margins Return on Equity Return on Assets
Cambridge Cognition-10.07% -68.83% -0.30%
Kooth 7.89%18.59%10.12%

In the previous week, Kooth had 6 more articles in the media than Cambridge Cognition. MarketBeat recorded 7 mentions for Kooth and 1 mentions for Cambridge Cognition. Cambridge Cognition's average media sentiment score of 0.88 beat Kooth's score of 0.18 indicating that Cambridge Cognition is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cambridge Cognition
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Kooth
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Kooth beats Cambridge Cognition on 13 of the 16 factors compared between the two stocks.

Get Cambridge Cognition News Delivered to You Automatically

Sign up to receive the latest news and ratings for COG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COG vs. The Competition

MetricCambridge CognitionHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£18.39M£359.19M£5.75B£2.61B
Dividend YieldN/A5.89%5.75%5.33%
P/E Ratio-1,032.63528.0675.775,391.08
Price / Sales1.99253.70544.6298,185.24
Price / Cash4.3147.1437.5427.92
Price / Book5.405.1112.878.52
Net Income-£1.58M-£15.55M£3.29B£5.89B
7 Day Performance4.42%0.28%0.28%8.10%
1 Month Performance56.27%4.40%2.87%2.42%
1 Year Performance6.05%15.16%65.66%159.66%

Cambridge Cognition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COG
Cambridge Cognition
N/AGBX 39.24
-1.9%
N/A+8.7%£18.39M£9.05M-1,032.6380Gap Up
KOO
Kooth
1.8069 of 5 stars
GBX 151.25
-0.2%
GBX 395
+161.2%
-56.2%£54.23M£66.74M720.24478News Coverage
Earnings Report
Analyst Forecast
RENX
Renalytix
N/AGBX 8.20
+12.3%
N/A+8.1%£27.16M£2.37M-51.25102Gap Up
High Trading Volume
INHC
Induction Healthcare Group
N/AGBX 9.75
flat
N/A+39.3%£9.00M£12.57M-1.7674
FDBK
Feedback
N/AGBX 11.56
-1.6%
N/A-75.0%£5.07M£1.19M-47.3024High Trading Volume
IQAI
IQ-AI
N/AGBX 0.80
flat
N/A-27.5%£1.77M£538.19K-13.676Gap Up
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
TRLS
Trellus Health
N/AGBX 0.60
+4.3%
N/A-56.9%£969K£114K-12.0031Gap Up
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
2.0112 of 5 stars
GBX 2,400
-7.7%
GBX 2,873.67
+19.7%
+1.4%£849.84M£205.66M5,647.06734

Related Companies and Tools


This page (LON:COG) was last updated on 9/26/2025 by MarketBeat.com Staff
From Our Partners